Platelets are a major player and represent a therapeutic opportunity in systemic lupus erythematosus
Authors:
- 24 July 2023
- journal article
- review article
- Published by Elsevier in Joint Bone Spine
- Vol. 91 (1) , 105622
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- Characterization of platelet aminophospholipid externalization reveals fatty acids as molecular determinants that regulate coagulationProceedings of the National Academy of Sciences, 2013
- Platelets Present Antigen in the Context of MHC Class IThe Journal of Immunology, 2012
- Protective Roles for Fibrin, Tissue Factor, Plasminogen Activator Inhibitor-1, and Thrombin Activatable Fibrinolysis Inhibitor, but Not Factor XI, during Defense against the Gram-Negative Bacterium Yersinia enterocoliticaThe Journal of Immunology, 2011
- P-Selectin–Mediated Platelet-Neutrophil Aggregate Formation Activates Neutrophils in Mouse and Human Sickle Cell DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Immature myeloid dendritic cells capture and remove activated platelets from preformed aggregatesJournal of Thrombosis and Haemostasis, 2010
- Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle ProductionScience, 2010
- Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activityArthritis Research & Therapy, 2009
- Functional expression of IgA receptor FcαRI on human plateletsJournal of Leukocyte Biology, 2008
- Platelet adhesion to dimeric β2‐glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibα and apolipoprotein E receptor 2′Journal of Thrombosis and Haemostasis, 2007
- Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease*Clinical and Laboratory Haematology, 2002